Endonovo Therapeutics, Inc.
Get Full AccessDescription
- Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. Endonovo's Immunotronics platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. Endonovo's Cytotronics platform provides for a method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields (TVEMF) for tissue engineering and cell therapies.
-
Headquarters:6320 Canoga Avenue , Woodland Hills, California, United States
More -
Phone Number: +1 800-489-4774
-
Website: https://www.endonovo.com
-
Employees:6
-
Revenue:$1 - 10M
-
Legal Name:Endonovo Therapeutics, Inc.
-
Endonovo Therapeutics, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Endonovo Therapeutics, Inc.
-
Where are Endonovo Therapeutics, Inc.'s Headquarters?
Endonovo Therapeutics, Inc.'s Headquarters are in 6320 Canoga Avenue ,Woodland Hills,California,United States
-
What is Endonovo Therapeutics, Inc.'s phone number?
Endonovo Therapeutics, Inc.'s phone number is +1 800-489-4774
-
What is Endonovo Therapeutics, Inc.'s official website?
Endonovo Therapeutics, Inc.'s official website is https://www.endonovo.com
-
What is Endonovo Therapeutics, Inc.'s Revenue?
Endonovo Therapeutics, Inc.'s revenue is $1 - 10M
-
What is Endonovo Therapeutics, Inc.'s NAICS code?
Endonovo Therapeutics, Inc.'s NAICS code is 325412
-
How many employees are working in Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. has 6 employees
-
What is Endonovo Therapeutics, Inc.'s Industry?
Endonovo Therapeutics, Inc. is in the industry of Biotechnology
-
Who is Endonovo Therapeutics, Inc.'s CEO?
Endonovo Therapeutics, Inc.'s CEO is Alan Collier

